General description
We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry. This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency".
Click here for more information.
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
Specificity
Clone 1D7 is a ZooMAb® rabbit recombinant monoclonal antibody that specifically detect Peroxisomal membrane protein PEX14. It targets an epitope within 23 amino acids from the C-terminal, cytoplasmic domain.
Immunogen
KLH-conjugated linear peptide corresponding to 23 amino acids from the C-terminal, cytoplasmic domain of human Peroxisomal membrane protein PEX14.
Application
Quality Control Testing
Evaluated by Western Blotting in HepG2 cell lysate.
Western Blotting Analysis: A 1:10,000 dilution of this antibody detected PEX14 in HepG2 cell lysate.
Tested Applications
Western Blotting Analysis: A 1:10,000 dilution from a representative lot detected PEX14 in lysates from NIH3T3 and C2C12 cells and Human Small intestine tissue and 1:1,000 dilution detected PEX14 in MDA-MB-23 cell lysate.
Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected PEX14 in Human small intestine tissue sections.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected PEX14 in HepG2 cells.
Flow Cytometry Analysis: 1 µg from a representative lot detected PEX14 in one million HepG2 cells.
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Target description
Peroxisomal membrane protein PEX14 (UniProt: O75381; also known as PTS1 receptor-docking protein, Peroxin-14, Peroxisomal membrane anchor protein PEX14) is encoded by the PEX14 gene (Gene ID: 5195) in human. PEX14 is a single-pass membrane protein with a peroxisomal matrix domain (aa 2-108), a transmembrane domain (aa 109-126), and a cytosolic domain (aa 127-277). PEX14 is a multi-tasking protein that facilitates peroxisomal protein import and is also required for peroxisome motility by serving as membrane anchor for microtubules. PEX14 is integrated into peroxisome membranes with its C-terminus exposed to the cytosol and interacts with the cytosolic receptor for proteins containing a PTS1 peroxisomal targeting signal. It interacts with PEX13 to form the PEX13-PEX14 docking complex and is an essential component of the peroxisomal translocon that mediates import of cargo enzymes into peroxisomes. It also interacts with PEX5 via WxxxF/Y motifs. Mechanistically, PEX5 receptor along with cargo proteins associates with the PEX14 subunit of the PEX13-PEX14 docking complex in the cytosol, leading to the insertion of the receptor into the organelle membrane with the concomitant translocation of the cargo into the peroxisome matrix. Two isoforms of PEX14 have been described that are produced by alternative splicing. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Gaussmann, S., et al. (2021). Front. Cell Dev. Biol. 9; 651449; Neuhaus, A., et al. (2014). J. Biol. Chem. 289(1); 437-448; Bharti, P., et al. (2011). J. Cell Sci. 124(10); 1759-1768; Fransen, M., et al. (1998). Proc. Natl. Acad. Sci. USA. 95(14); 8087-8092)
Physical form
Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.
Reconstitution
Reconstitute lyophilized antibody pellet with 25μL of ultrapure water or Phosphate Buffered Saline (PBS). Please refer to our
reconstitution protocol and the specific application guidance on the suggested starting dilutions and sample type.
Storage and Stability
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
Legal Information
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.